Pivotal Trial Fully Enrolled - Full Data Anticipated in 2010
10:30AM 12/06/09
Cramer's 'Mad Money' Recap: How to Play the Surprising Jobs Report (Update 3)
Cramer says an improving economy means stocks will be heading higher.
06:39PM 12/04/09
Onyx Pharmaceuticals To Host American Society Of Hematology (ASH) Investor Teleconference
04:00PM 12/04/09
--Four Abstract Presentations at the American Society of Hematology--
07:00AM 12/02/09
Research Firm Lays Out Surprise Bio Events for 2010: BioBuzz
Stocks will move if any of these unexpected events come true.
11:16AM 11/30/09
Onyx Pharmaceuticals Announces December 2009 Investor Events
American Society of Hematology (ASH) Briefing and Analyst Briefing
04:00PM 11/25/09
Paulson's Big Trade, Bearish Bets and Biotech
Guests include Gregory Zuckerman, author of 'The Greatest Trade Ever', Steven Lehman, portfolio manager for the Federated Market Opportunity fund and Adam Feuerstein, TheStreet.com's biotech reporter.
04:40PM 11/11/09
Blood Cancer Meeting Abstracts Released: BioBuzz
No data in Celgene abstract, disappointing investors.
12:16PM 11/10/09
Bristol Licenses Arthritis Drug: BioBuzz
Worldwide deal involves privately held Alder BioTherapeutics
09:20AM 11/10/09
Celgene in ASH Abstract Spotlight: BioBuzz
A blood cancer meeting also is important for Onyx, Cephalon and Ariad.
06:31AM 11/10/09
Cramer's 'Mad Money' Follow-Up: Nov. 6
Here's how some of Thursday's 'Mad Money' stocks fared on Friday.
04:49PM 11/06/09
Cramer's 'Mad Money' Recap: The Rich Are Spending Again (Final)
Cramer says the return to luxury bodes well for the retail sector and American Express. Click for news from Jim Cramer.
06:31PM 11/05/09
The Bull and Bear Story on GTx's Pending Drug Decision: BioBuzz
Acapodene faces an FDA decision Friday.
10:56AM 10/27/09
Big-Cap Biotech Worries Lead Sector Down: BioBuzz
Getting answers to why biotech is underperforming.
07:37AM 10/27/09
It's a battle of upgrades vs. downgrades.
11:23AM 10/13/09



Connect with TheStreet